EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS026-08552 
Organism
Homo sapiens 
Tissue/cell
CNCC 
Coordinate
chr12:109249360-109251200 
SNPs
Number: 1             
IDChromosomePositionGenome Version
rs987044chr12109250356hg19
Number of super-enhancer constituents: 35             
IDCoordinateTissue/cell
SE_00113chr12:109244424-109251439Adipose_Nuclei
SE_01037chr12:109249271-109251865Adrenal_Gland
SE_01623chr12:109246181-109252083Aorta
SE_02246chr12:109246168-109252078Astrocytes
SE_04650chr12:109249244-109251148Brain_Anterior_Caudate
SE_06218chr12:109246114-109251372Brain_Hippocampus_Middle
SE_08617chr12:109249226-109251457Brain_Inferior_Temporal_Lobe
SE_09493chr12:109247147-109253018CD14
SE_25830chr12:109244536-109251201Duodenum_Smooth_Muscle
SE_26704chr12:109246214-109251864Esophagus
SE_29719chr12:109249196-109251365Fetal_Muscle
SE_32104chr12:109249273-109251984Gastric
SE_34450chr12:109246280-109252128HCT-116
SE_34725chr12:109245953-109252240HeLa
SE_36100chr12:109246988-109251401HMEC
SE_36924chr12:109244176-109251762HSMMtube
SE_37947chr12:109244148-109252158HUVEC
SE_38903chr12:109246069-109251429IMR90
SE_40657chr12:109245919-109253030Left_Ventricle
SE_42149chr12:109245912-109252798Lung
SE_44139chr12:109246155-109251395NHDF-Ad
SE_44751chr12:109244532-109252762NHLF
SE_45545chr12:109244280-109252952Osteoblasts
SE_47346chr12:109244433-109251321Panc1
SE_48097chr12:109245995-109252101Psoas_Muscle
SE_48602chr12:109245944-109251883Right_Atrium
SE_49578chr12:109249348-109251413Right_Ventricle
SE_50432chr12:109246119-109251878Sigmoid_Colon
SE_51142chr12:109244391-109251449Skeletal_Muscle
SE_51706chr12:109246219-109251409Skeletal_Muscle_Myoblast
SE_52666chr12:109246054-109251874Small_Intestine
SE_53376chr12:109245391-109252770Spleen
SE_63492chr12:109246142-109251594HSMM
SE_65195chr12:109247561-109251325NHEK
SE_68566chr12:109231845-109256560TC71
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr12109249389109249909
chr12109250000109250362
Enhancer Sequence
GAAATCTGGG CTGACAGGTT CAGCCTGAAG CCAACCTCTC CCCTTACCTC ACATAAACTT 60
TTGTGATGAG AACCTGAGAT TAAGTGCATA AATTGCCAGA CAGCAGTGAC CGGAACAGAA 120
AACAGCCCCT CCTCGCTGTG GGAAGGAAAG GCGCTCCTGC AACCTAACTT CTCAGTAGCA 180
GGCTATTGAT CGCCAGTGTT CTTTTGCCTC TAATCAGCGT GTAGAGGGGG ATTACTAGAA 240
CCTTCTGTGT ATAGATAACT CATGAATGGC CTCTCCTCTC CAAGGAGGGG GCTGTGAAGG 300
TTCAACTTCC CAGCCACTCT GAAAATGTCC CTGCCAATCC CAGCAAAACA AGGCTGAAGA 360
ACTACCCTAC CAGGAGACAG GGCTGTCAAG CCAAATGCAA ACATTATTCT CTTGTCTCTC 420
TCAGACACAC AAACCTCCCC CGTGTTATCA GTCAACTTCC CCCACTCCCT CCCACAAAGA 480
AAGGGGCTGA AGAGCCCAGA TGCTGGCTGC GGAACTTCCT GGGCCTGGGA CCGCAGGGCC 540
GCTCCTCCAG TCTTCTCTAA ACACAGCTAA GGGTCTGCAG GCGGACACTC AGCCTTGTTA 600
TAGGTAAGAG TTTAGACCAG AGGCCTTGAC GGGTTCTTCA AGAGATGGTG GGCAAGATTG 660
CGCGACCAGA GGGTCATCCC TGCAGCTACA GAGGGCTGAC CTGCTCAGAG GCCCAAGGCC 720
CCAGCCTAGG ACAAGCCAGG CCAACCCTGC AGGCTAAGAG GGCAACAGTG CCCTCAATCA 780
ACCCCAGAGG AAAAAGTGGC CAGGCAAACG GACCTGGGCC ACACACAGAC CCACAAAAAC 840
GCGCACAGTG CCAGGACACG CAACCCAGGA ATGCACCTAT GCAATCACCC AGAATGGGTC 900
ACAGCCACAC AGAAAGATAG ATGCACATAA ACACACAGGC CTGAGTGATG TTACAGAAAG 960
GAAAAGCCAG ACTAAGGCTG CACGCACAGA CGTGAAACAC AGCCACACAG AGCCCACAGC 1020
ACGCTCGGTC ACCGTCACAC AGTGACACGG GCACGCCTAC AGACAGAACT CCAGAGGCGG 1080
CAGGCGGGGA AACAATCTCA CACGTTTGTA GGGGCACTCC CAGATGCCTG TCTCACGCTG 1140
GCACAGTCCC CGGACGGCAG GTCAGCAACA GTCACATCTC ACATCGCACA GCCAGGCATA 1200
CAGGCAAAGG GCCTAGAACT ACCCCGGCCA CAGGTCTCAG AACCAGCGGC TCACGCAGTC 1260
ACCCAATCAA GGGTCCCAGT TGCACATCCA GTCACCCCTG GACCCTGGTC ACACTGCAGA 1320
GTCACTCACA AATGGGAGTC CCGACAGACG CACAGTCCTC CCCAGACAGA GGTCAACCCA 1380
AGATGGGGGT CACACCTGAA ATCACAGTCC CCACACAATC ACGAGGTCAC ATCTGCACAC 1440
ACAGTCTCTG CACAGTCACC CTTAGGGGTC ACAACGCACA CAGTCTCCGC CTAACAGGGG 1500
TCACCCCAAG ATGGGGGTAA CCCCCTGATG TGGGTCACAG CGCACACACA GTATCCTGCA 1560
GACACTCCCA GAGGGGTCGC ACTGCATACA CAGTCCCTGC AAAGTCGCCC CCCGATAGGG 1620
GTCACACCGC ACACAAAGTC CCCGCACAGC TCCCCAAGAC AGGGTCACAT CGCACACAGT 1680
CCTCGCACGG TCACCCCGGT CCGGCTGCCC GGCTCTGTTC CTACGGCGGG GCCCCGAGGA 1740
GCCCGCGCAG CCGCCCCCCT GCCCCGCACG CGCGGCCCCA GCTCCGGCGG CCTCGGCGCG 1800
GCGTCCGGCG GCCCAGGCCG GGCGCGGCGA GCCCGGGGCT 1840